Stories

If you want decrease costs in myeloma – Aaron Goodman

Photo from Aaron Goodman/X

Jul 8, 2023, 11:43

If you want decrease costs in myeloma – Aaron Goodman

If you want decrease costs in myeloma then

1. Don’t treat smoldering MM

2. Don’t follow MGUS with routine labs

3. Don’t use Zometa q1 most

4. Don’t use denosumab

5. Don’t follow MRD outside of trial

6. Don’t use drugs with no meaningful impact yet high toxicity

Source: Aaron Goodman/Twitter

Aaron Goodman cancer Drugs MGUS MRD Myeloma OncoDaily Oncology Zometa

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Insight

Aug 21, 2025, 20:26

Kevin Harrington Looks Forward to CONCORDE Study Results on DNA Damage Inhibitors and Radiotherapy

Voices

Aug 21, 2025, 20:00

Raymond Mailhot: Advancing Hodgkin Lymphoma Survivor Study with NCI Funding

Voices

Aug 21, 2025, 19:28

Parvati Tiwari: Advocates Express Alarm Over NCI’s Decision to End PBTC Funding for Pediatric Brain Tumor Trials

Voices

Aug 21, 2025, 15:59

George Kumar: The interplay Between Cardiovascular Disease (CVD) and Cancer

Voices

Aug 21, 2025, 15:47

European Society of Gynaecological Oncology Announces that Applications are Open for Editor-in-Chief of IJGC

Insight

Aug 21, 2025, 15:37

Carolina Reduzzi: ctDNA Landscape Analysis Post CDK4/6 Inhibitor in HR+/HER2- Metastatic Breast Cancer

Voices

Aug 21, 2025, 15:30

Clinician-Scientists Awarded NMRC Transition Awards for Precision Lung Cancer Research - National Cancer Centre Singapore

Voices

Aug 21, 2025, 15:22

Construction of the $658 million Sydney Children’s Hospital Stage One and MCCCC Project Has Reached Completion

Oncolibrary

Aug 21, 2025, 15:00

Breakthrough Emactuzumab Phase 3 TANGENT Trial in TGCT: SynOx Pharma Reports Enrollment Completed Ahead of Schedule

Voices

Aug 21, 2025, 14:50

Andrea Apolo Highlights the Top 5 Clinical Advances in Bladder Cancer Treatment for 2024

Insight

Aug 21, 2025, 14:47

Loay Kassem: Study Reveals BRCA Mutation Rates in Egyptian Women with Breast or Ovarian Cancer

Insight

Aug 21, 2025, 14:41

Tiago Cordeiro Felismino: Exploring the Role of Neutrophil-to-Lymphocyte Ratio in Advanced HCC Treatment